Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Consistency of Drug Sensitivity in Vitro and Neoadjuvant Chemotherapy Results in Vivo for Early Breast Cancer Patients

NCT04131881 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT04131881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04131881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Consistency of Drug Sensitivity in Vitro and Neoadjuvant Chemotherapy Results in Vivo for Early Breast Cancer Patients
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Completed
Start date
April 1, 2017
Completion date
September 1, 2019
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, drug effect